Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Guys and St Thomas's NHS Foundation Trust (GSTT) has been awarded Funding from NHS England (NHSE) and the Department of Science, Innovation and Technology (the "Funders") for the financial years 2023/24 and 2024/25 as the lead provider for the delivery of the Respiratory Metagenomic Clinical Service Development Programme (the 'Project'), from Oxford Nanopore Technologies PLC.
The Project is a pilot based on patented nanopore based sequencing technology and therefore this contract notice is issued under Regulation 32 (a) of the PCR 2015.
The Project aims to deliver a national respiratory metagenomics (RMg) pilot clinical service with an integrated biosecurity surveillance purpose, as a world-first programme to combine effective infectious disease management with rapid emerging pathogen detection and notification.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | 05386273 | £376,110 | - |
Government spending data: This supplier has received £144,544,480 in 170 payments (over £25k) from Department of Health and Social Care, UK Health Security Agency, DSIT, Guy's and St Thomas' NHS FT, Forestry Commission and 3 more public bodies (2020-05-06 to 2026-03-24). View full payment history →